Gradual Vs. Rapid Buprenorphine Detoxification - 2 - Tabular View

Tracking Information

First Received Date ^ICMJE

September 20, 1999

Last Updated Date

June 23, 2005

Start Date ^ICMJE

June 1991

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Drug use
Retention
Observed withdrawal rating
Opioid agonist rating
Opioid antagonist rating

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00000220 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Official Title ^ICMJE

Gradual Vs. Rapid Buprenorphine Detoxification

Brief Summary

The purpose of this study is to determine an optimal detoxification dose reduction schedule with buprenorphine.

Detailed Description

Study Phase

Phase I

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Double-Blind

Condition ^ICMJE

Opioid-Related Disorders

Intervention ^ICMJE

Drug: Buprenorphine

Study Arms / Comparison Groups

Publications *

Amass L, Bickel WK, Higgins ST, Hughes JR. A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification. J Addict Dis. 1994;13(3):33-45.

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

July 2001

Primary Completion Date

Eligibility Criteria ^ICMJE

Please contact site for information.

Gender

Both

Ages

33 Years to 43 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00000220

Responsible Party

Study ID Numbers ^ICMJE

NIDA-06969-2, R01-06969-2

Study Sponsor ^ICMJE

National Institute on Drug Abuse (NIDA)

Collaborators ^ICMJE

University of Vermont

Investigators ^ICMJE

Principal Investigator:

Warren Bickel, Ph.D.

University of Vermont

Information Provided By

National Institute on Drug Abuse (NIDA)

Verification Date

September 1991

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP